Skip to content
TrialScanner

NCT03712345

Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPA

Phase 2TerminatedIFRXLeadIQVCollaborator

Registry record

Lead sponsor
InflaRx GmbH
Conditions
Granulomatosis With Polyangiitis (GPA); Microscopic Polyangiitis (MPA)
Primary completion
Sep 10, 2020Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03712345 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03712345: Safety and Efficacy Study of... | TrialScanner